These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 10702763

  • 1. A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity.
    Fanghänel G, Cortinas L, Sánchez-Reyes L, Berber A.
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):144-50. PubMed ID: 10702763
    [Abstract] [Full Text] [Related]

  • 2. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
    Fanghänel G, Cortinas L, Sánchez-Reyes L, Berber A.
    Int J Obes Relat Metab Disord; 2001 May; 25(5):741-7. PubMed ID: 11360159
    [Abstract] [Full Text] [Related]

  • 3. Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population.
    Cuellar GE, Ruiz AM, Monsalve MC, Berber A.
    Obes Res; 2000 Jan; 8(1):71-82. PubMed ID: 10678261
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study.
    Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P.
    Int J Obes Relat Metab Disord; 1998 Jan; 22(1):32-8. PubMed ID: 9481597
    [Abstract] [Full Text] [Related]

  • 6. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 8. Long-term weight loss with sibutramine: a randomized controlled trial.
    Wirth A, Krause J.
    JAMA; 2001 Sep 19; 286(11):1331-9. PubMed ID: 11560538
    [Abstract] [Full Text] [Related]

  • 9. A comparison of sibutramine and dexfenfluramine in the treatment of obesity.
    Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P.
    Obes Res; 1998 Jul 19; 6(4):285-91. PubMed ID: 9688105
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.
    McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD.
    Arch Intern Med; 2000 Jul 24; 160(14):2185-91. PubMed ID: 10904462
    [Abstract] [Full Text] [Related]

  • 11. Effects of sibutramine treatment in obese adolescents: a randomized trial.
    Berkowitz RI, Fujioka K, Daniels SR, Hoppin AG, Owen S, Perry AC, Sothern MS, Renz CL, Pirner MA, Walch JK, Jasinsky O, Hewkin AC, Blakesley VA, Sibutramine Adolescent Study Group.
    Ann Intern Med; 2006 Jul 18; 145(2):81-90. PubMed ID: 16847290
    [Abstract] [Full Text] [Related]

  • 12. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
    Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.
    Diabetes Obes Metab; 2000 Apr 18; 2(2):105-12. PubMed ID: 11220522
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan 18; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 14. [A randomized, double-blind, placebo-controlled, multicenter study on sibutramine in over-weighted and obese subjects].
    Zhao Y, Wang X, Yan Z.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep 18; 35(5):329-32. PubMed ID: 11769634
    [Abstract] [Full Text] [Related]

  • 15. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.
    Clin Ther; 2004 Sep 18; 26(9):1427-35. PubMed ID: 15531005
    [Abstract] [Full Text] [Related]

  • 16. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.
    Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP, Sibutramine/Diabetes Clinical Study Group.
    Diabetes Obes Metab; 2000 Jun 18; 2(3):175-87. PubMed ID: 11220553
    [Abstract] [Full Text] [Related]

  • 17. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.
    Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL.
    JAMA; 2003 Apr 09; 289(14):1805-12. PubMed ID: 12684359
    [Abstract] [Full Text] [Related]

  • 18. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM, Balance Study Group.
    Eur J Clin Nutr; 2005 Aug 09; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of efficacy, reliability, and tolerability of sibutramine in obese patients, with an echocardiographic study.
    Halpern A, Leite CC, Herszkowicz N, Barbato A, Costa AP.
    Rev Hosp Clin Fac Med Sao Paulo; 2002 Aug 09; 57(3):98-102. PubMed ID: 12118266
    [Abstract] [Full Text] [Related]

  • 20. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.
    Smith IG, Goulder MA, Sibutramine Clinical Study 1047 Team.
    J Fam Pract; 2001 Jun 09; 50(6):505-12. PubMed ID: 11407998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.